BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27926553)

  • 21. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
    Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
    Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node involvement in colon cancer patients decreases with age; a population based analysis.
    Khan H; Olszewski AJ; Somasundar P
    Eur J Surg Oncol; 2014 Nov; 40(11):1474-80. PubMed ID: 25027280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
    Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
    Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adequacy and importance of lymph node evaluation for colon cancer in the elderly.
    Bilimoria KY; Stewart AK; Palis BE; Bentrem DJ; Talamonti MS; Ko CY
    J Am Coll Surg; 2008 Feb; 206(2):247-54. PubMed ID: 18222376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancers.
    Lim M; Hussain Z; Howe A; Storey R; Petty D; Haselden J; Sebag-Montefiore D; Alexander D
    Colorectal Dis; 2013 May; 15(5):536-43. PubMed ID: 23067005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
    Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
    Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking surgical specimen length and examined lymph nodes in colorectal cancer patients.
    Stracci F; Bianconi F; Leite S; Liso A; La Rosa F; Lancellotta V; van de Velde CJ; Aristei C
    Eur J Surg Oncol; 2016 Feb; 42(2):260-5. PubMed ID: 26723169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
    Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
    J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing the number of lymph nodes examined after colectomy does not improve colon cancer staging.
    Budde CN; Tsikitis VL; Deveney KE; Diggs BS; Lu KC; Herzig DO
    J Am Coll Surg; 2014 May; 218(5):1004-11. PubMed ID: 24661856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.
    Margalit O; Mamtani R; Lawrence YR; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Clin Colorectal Cancer; 2019 Sep; 18(3):226-230.e2. PubMed ID: 31097386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally invasive surgery for T4 colon cancer is associated with better outcomes compared to open surgery in the National Cancer Database.
    El-Sharkawy F; Gushchin V; Plerhoples TA; Liu C; Emery EL; Collins DT; Bijelic L
    Eur J Surg Oncol; 2021 Apr; 47(4):818-827. PubMed ID: 32951935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.